Clinical trial
A Study to Evaluate the Safety, Tolerability, PK and PD of HNC364 Injectable Suspension
NCT05523570
Study timeline
Study start (actual)2022-08-22Date precision: day
Registry last updated2024-09-27
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Parkinson's Diseaseunresolved
Interventions
Sponsors & collaborators
Guangzhou Henovcom Bioscience Co. Ltd.lead sponsor
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT05523570 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.